BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 22, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 11, 1998

View Archived Issues

Israeli investigators describe studies with novel vitamin D analogue

Read More

Hemosol: six-month 1998 highlights

Read More

Guilford: Q2 1998 highlights

Read More

IBT-9302 demonstrates therapeutic value in the treatment of traumatic shock

Read More

Medtronic releases novel cardiac device with diagnostic and therapeutic capabilities in Europe

Read More

OspA vaccine prevents Lyme disease and asymptomatic infection

Read More

4030W92 antihyperalgesic effect due to preferential action on slow activation state of Na+ channel

Read More

Professional advises against the use of antioxidant vitamins for the prevention of heart disease

Read More

Antifungal activity of NS-718 highly effective against C. neoformans infections

Read More

Dual-action angiotensin II blockers/smooth cell proliferation inhibitors from Bayer

Read More

Genentech discovers novel polypeptides for treating shock

Read More

New CNS agents described by French team

Read More

Yeda, Yissum collaborate in the discovery of tyrosine kinase inhibitors

Read More

Hoechst describes new compounds for rheumatoid arthritis and allergy

Read More

FDA committee recommends approval of Arava for the treatment of rheumatoid arthritis

Read More

Byk Gulden researchers synthesize PDE IV inhibitors with broad therapeutic potential

Read More

Bayer discovers new MMP inhibitors for arthritic diseases

Read More

Cognetix expands drug discovery capabilities with Viatech Imaging acquisition

Read More

COX-2 inhibitors selective for the human enzyme discovered at Nycomed Innovations

Read More

New agents for treating constipation presented at IUPHAR meeting

Read More

MABE: a new enkephalin analogue with analgesic potential

Read More

New antiplatelet agent, PDE III inhibitor, reported by Taiwanese scientists

Read More

Searle withdraws support for development of CCD-3693; CoCensys will forge ahead

Read More

Studies with spheron-targeted AD treatment candidate yield promising results

Read More

RS-601, a dual-action TxA2/LTD4 antagonist with potent antiasthmatic effects

Read More

Dual ETA/ETB antagonist provides effective blood pressure control in rats

Read More

OPC-51803, a vasopressin V2 agonist with potent antidiuretic activity in rats and dogs

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 22, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing